Targeted Abdominal CT in Conjunction With Lung Cancer Screening

Recruiting N/A Interventional Study
Renal Cell Carcinoma (Kidney Cancer) Kidney Cancers AAA - Abdominal Aortic Aneurysm Renal Stones
No Placebo Group Every participant receives an active treatment — no one gets a placebo. Healthy Volunteers Welcome You do not need to have the condition being studied to take part.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
55 – 70
Sex
Any
Study type
Interventional
Purpose
Screening
Participants needed
6,272 (estimated)
Sponsor
University of Cambridge · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Early detection through screening can improve cancer survival by identifying it when it's most treatable. The NHS now offers Lung Cancer Screening (LCS) assessments to people aged 55-74 who have ever smoked. Those at higher risk of lung cancer are offered a lung scan. This group also has a high risk of developing abdominal cancers, such as kidney cancer. A recent study explored whether it would b…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
1. For the individual level randomisation to invitation control or invitation intervention Inclusion criteria: To be randomised at the individual level to receive an invitation letter for LCS (standard of care; invitation control) versus invitation letter for LCS with potential for an additional…
Contacts

Grant Stewart

01223 331199

gds35@cam.ac.uk

CONTACT

Jessica Kitt

jk896@cam.ac.uk

CONTACT